Status
Conditions
Treatments
About
Primary Objective:
Efficacy of Occupational Therapy (OT) based Occupational Goal Intervention (OGI) in improving executive functions in patients with refractory schizophrenia as measured by the BADS.
Secondary Objectives: improvement of functional aspects,basic and instrumental activities of daily living,negative symptoms and cognitive functions improvement
Hypothesis: OT is more effective than control group to improve executive functions in patients with refractory schizophrenia.
Full description
A single-center, randomized, single blind, controlled study, lasting one year, including the follow-up.
The study is conducted in two groups:the experimental group is based on the OGI method (N=30 patients) and the control group receives craft activities (N = 30 patients).
Psychiatric, neuropsychological and functional aspects are assessed at the beginning, after 30 sessions and 6 months after the intervention. The scale PANSS (Positive and Negative Syndrome Scale) is used for monitoring psychopathological symptoms during the study.
Scales BADS, DAFS-R, ILSS-BR respectively assess executive functions, functionality and basic and instrumental activities of daily living. The neuropsychological evaluation includes a battery to measure attention, executive functions, memory and estimated intellectual efficiency.
Statistical analysis to be used: ANOVA (Analysis of Variance)for repeated measures; data are also calculated to messure clinical efficacy, effect size and needed number to treat.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Pacients with diagnosis of schizophrenia for DMS IV-R.
Pacients that signed the consent in writing and receive explanations about the nature of the study.
Patients who carefully counted another responsible person to provide reliable support to the patient and ensure adherence to the same study treatment.
Patients with minimum education: five years (elementary school).
Patients with stable clozapine and which have not been recently admitted (3 months).
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Helio Elkis, MD PhD; Adriana Vizzotto, BSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal